Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
Kriaa
F
F
Nephrology Department, Hôpital de Bicêtre, Université Paris-Sud, France.
Hiesse
C
C
Alard
P
P
Lantz
O
O
Noury
J
J
Charpentier
B
B
Bazin
H
H
D000206:Actuarial Analysis; D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D002102:Cadaver; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007074:Immunoglobulin G / Q000145:classification / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D011336:Probability; D051381:Rats; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D016019:Survival Analysis
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2